Next Article in Journal
High Accuracy Acoustic Relative Humidity Measurement inDuct Flow with Air
Next Article in Special Issue
Acute Response in vivo of a Fiber-Optic Sensor for Continuous Glucose Monitoring from Canine Studies on Point Accuracy
Previous Article in Journal
Observing the Forest Canopy with a New Ultra-Violet Compact Airborne Lidar
Previous Article in Special Issue
“Smart” Continuous Glucose Monitoring Sensors: On-Line Signal Processing Issues
Sensors 2010, 10(8), 7404-7420; doi:10.3390/s100807404
Review

Use of Sensors in the Treatment and Follow-up of Patients with Diabetes Mellitus

,
,
,
 and
*
Received: 29 June 2010 / Revised: 28 July 2010 / Accepted: 6 August 2010 / Published: 9 August 2010
(This article belongs to the Special Issue Glucose Sensors)
View Full-Text   |   Download PDF [185 KB, uploaded 21 June 2014]   |   Browse Figure

Abstract

Glucose control is the cornerstone of Diabetes Mellitus (DM) treatment. Although self-regulation using capillary glycemia (SRCG) still remains the best procedure in clinical practice, continuous glucose monitoring systems (CGM) offer the possibility of continuous and dynamic assessment of interstitial glucose concentration. CGM systems have the potential to improve glycemic control while decreasing the incidence of hypoglycemia but the efficiency, compared with SRCG, is still debated. CGM systems have the greatest potential value in patients with hypoglycemic unawareness and in controlling daily fluctuations in blood glucose. The implementation of continuous monitoring in the standard clinical setting has not yet been established but a new generation of open and close loop subcutaneous insulin infusion devices are emerging making insulin treatment and glycemic control more reliable.Glucose control is the cornerstone of Diabetes Mellitus (DM) treatment. Although self-regulation using capillary glycemia (SRCG) still remains the best procedure in clinical practice, continuous glucose monitoring systems (CGM) offer the possibility of continuous and dynamic assessment of interstitial glucose concentration. CGM systems have the potential to improve glycemic control while decreasing the incidence of hypoglycemia but the efficiency, compared with SRCG, is still debated. CGM systems have the greatest potential value in patients with hypoglycemic unawareness and in controlling daily fluctuations in blood glucose. The implementation of continuous monitoring in the standard clinical setting has not yet been established but a new generation of open and close loop subcutaneous insulin infusion devices are emerging making insulin treatment and glycemic control more reliable.
Keywords: diabetes mellitus; sensors; glucose controldiabetes mellitus; sensors; glucose control diabetes mellitus; sensors; glucose controldiabetes mellitus; sensors; glucose control
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Torres, I.; Baena, M.G.; Cayon, M.; Ortego-Rojo, J.; Aguilar-Diosdado, M. Use of Sensors in the Treatment and Follow-up of Patients with Diabetes Mellitus. Sensors 2010, 10, 7404-7420.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Sensors EISSN 1424-8220 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert